Oncology
Cancer Crosslinks
Cancer Crosslinks is an educational meeting series which promotes interactions between researchers and clinicians, and encourages translational and clinical research to support collaborations to advance the...
Tackling The Talent Shortfall In Cell And Gene Therapy
The Advanced Therapy Medicinal Products (ATMPs) sector, an area of medicine specialised in gene, tissue and cell therapies, is expanding at an incredibly fast...
Placement | The RSA Group completes successful search for Fusion Antibodies – Dr Richard Jones appointed as Chief Executive Officer
Following a successful search, The RSA Group is pleased to announce the placement of Dr Richard Jones as Chief Executive Officer at Fusion Antibodies,...
Lateral thinking for oncology leadership
The rapid growth in immuno-oncology therapeutics is causing talent headaches for the pharma industry Patients are already benefitting from pharma’s success in developing new...